2059 |
Statin for Better Outcome in Patients with ACS |
Kyung Woo Park |
May. 08. 14 |
2058 |
Anticoagulant Therapy in ACS: Should Bivalirudin Be the Anticoagulant of Choice for STEMI Intervention? - Against: No, Heparin with Provisional GPI Remains in the Standard of Care! |
Neal S. Kleiman |
May. 08. 14 |
2057 |
Anticoagulant Therapy in ACS: Should Bivalirudin Be the Anticoagulant of Choice for STEMI Intervention? - For: Yes, It Is So Simple and Really Effective! |
Mun Kyung Hong |
May. 08. 14 |
2056 |
Pretreatment with P2Y12 Inhibitors: Is It Necessary Prior to PCI in NSTE-ACS? - Against: No, Little Evidences, No Benefits! |
Philippe Garot |
May. 08. 14 |
2055 |
Pretreatment with P2Y12 Inhibitors: Is It Necessary Prior to PCI in NSTE-ACS? - For: Yes, Nothing to Lose, Everything to Gain! |
Sorin Brener |
May. 08. 14 |
2054 |
Symplicity HTN 3: Where Are We Going to? |
David E. Kandzari |
May. 08. 14 |
2053 |
Do You Want to Treat?: Functionally Insignificant Vulnerable Plaque - No, I Don\'t. We Can\'t Predict Fate of Vulnerable Plaque. |
Seung-Jung Park |
May. 08. 14 |
2052 |
Do You Want to Treat?: Functionally Insignificant Vulnerable Plaque - Yes, I Do. It Will Save Lives and Prevent ACS. |
Akiko Maehara |
May. 08. 14 |
2051 |
Left Atrial Appendage Occlusion: Results and Future Predictions |
David R. Holmes |
May. 08. 14 |
2050 |
Next-generation Invasive Imaging: 3D-OCT, HR IVUS and NIRS - Where Are We Going? |
Gary S. Mintz |
May. 08. 14 |